BRIEFING

 Leflunomide Compounded Oral Suspension. This proposal is based on the version of the monograph official as of March 1, 2019. It is proposed to add an Appearance requirement and Antimicrobial Effectiveness Testing 〈51〉 information to the Beyond-Use Date section.

 Additionally, minor editorial changes have been made to update the monograph to current USP style.

 Please submit comments to CompoundingSL@usp.org.

 (CMP. L. Pearson)

 Case ID—SUB-666